Get the Stockscreener App
8.11
0.25%
+0.02
Pre-market:
8.24
0.13
+1.60%
Global Medical REIT Inc stock is currently priced at $8.11, with a 24-hour trading volume of 318.95K.
It has seen a +0.25% increased in the last 24 hours and a -2.29% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $8.11 pivot point. If it approaches the $8.15 resistance level, significant changes may occur.
Previous Close:
$8.09
Open:
$8.13
24h Volume:
318.95K
Market Cap:
$531.91M
Revenue:
$140.93M
Net Income/Loss:
$20.61M
P/E Ratio:
25.34
EPS:
0.32
Net Cash Flow:
$58.39M
1W Performance:
-0.98%
1M Performance:
-2.29%
6M Performance:
-4.59%
1Y Performance:
-9.89%
1D Range:
$8.09
$8.2099
52W Range:
$7.98
$11.59
Global Medical REIT Inc Stock (GMRE) Company Profile
Name
Global Medical REIT Inc
Sector
Industry
Phone
-
Address
-
Global Medical REIT Inc Stock (GMRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-06-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jul-07-22 | Initiated | JMP Securities | Mkt Perform |
| Jan-13-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-20-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-09-21 | Initiated | Colliers Securities | Buy |
| Apr-16-21 | Initiated | BMO Capital Markets | Outperform |
| Sep-30-20 | Resumed | Robert W. Baird | Outperform |
| Sep-02-20 | Resumed | Stifel | Buy |
| Jul-01-20 | Initiated | Berenberg | Buy |
| Mar-18-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Mar-06-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Feb-07-20 | Initiated | National Securities | Buy |
| Jan-07-20 | Upgrade | Janney | Neutral → Buy |
| Apr-15-19 | Initiated | Stifel | Buy |
| Dec-20-18 | Downgrade | Janney | Buy → Neutral |
| Oct-11-18 | Initiated | Robert W. Baird | Outperform |
| Jul-11-17 | Resumed | FBR & Co. | Outperform |
| Jul-26-16 | Initiated | DA Davidson | Buy |
| Jul-25-16 | Initiated | Oppenheimer | Outperform |
| Jul-11-16 | Initiated | BB&T Capital Mkts | Hold |
| Jul-11-16 | Initiated | Compass Point | Buy |
| Jul-11-16 | Initiated | Wunderlich | Buy |
View All
Global Medical REIT Inc Stock (GMRE) Latest News
After Plunging -11.42% in 4 Weeks, Here's Why the Trend Might Reverse for Global Medical REIT (GMRE)
Zacks Investment Research
Global Medical REIT (GMRE) Misses Q4 FFO and Revenue Estimates
Zacks Investment Research
Insights Into Global Medical REIT (GMRE) Q4: Wall Street Projections for Key Metrics
Zacks Investment Research
City Office REIT (CIO) Q4 FFO Meet Estimates
Zacks Investment Research
Should You Buy Global Medical REIT (GMRE) After Golden Cross?
Zacks Investment Research
Plymouth Industrial (PLYM) Meets Q3 FFO Estimates
Zacks Investment Research
Global Medical REIT Inc Stock (GMRE) Financials Data
Global Medical REIT Inc (GMRE) Revenue 2024
GMRE reported a revenue (TTM) of $140.93 million for the quarter ending December 31, 2023, a +2.75% rise year-over-year.
Global Medical REIT Inc (GMRE) Net Income 2024
GMRE net income (TTM) was $20.61 million for the quarter ending December 31, 2023, a +7.67% increase year-over-year.
Global Medical REIT Inc (GMRE) Cash Flow 2024
GMRE recorded a free cash flow (TTM) of $58.39 million for the quarter ending December 31, 2023, a +173.30% increase year-over-year.
Global Medical REIT Inc (GMRE) Earnings per Share 2024
GMRE earnings per share (TTM) was $0.23 for the quarter ending December 31, 2023, a +15.00% growth year-over-year.
0.07%
0.45%
Cap:
|
Volume (24h):